Haplotypes in the Complement Factor H (CFH) Gene: Associations with Drusen and Advanced Age-Related Macular Degeneration

by Francis, Peter J., Schultz, Dennis W., Hamon, Sara, Ott, Jurg, Weleber, Richard G., Klein, Michael L.
Published 2007

Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension

by Kardia, Sharon LR, Sun, Yan V, Hamon, Sara C, Barkley, Ruth Ann, Boerwinkle, Eric, Turner, Stephen T
Published 2007

The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency

by Spellicy, Catherine J., Kosten, Thomas R., Hamon, Sara C., Harding, Mark J., Nielsen, David A.
Published 2013

Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment

by Levran, Orna, Peles, Einat, Hamon, Sara, Randesi, Matthew, Zhao, Connie, Zhang, Bin, Adelson, Miriam, Kreek, Mary Jeanne
Published 2011

Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy

by Koren, Michael J., Kereiakes, Dean, Pourfarzib, Ray, Winegar, Deborah, Banerjee, Poulabi, Hamon, Sara, Hanotin, Corinne, McKenney, James M.
Published 2015

Forced Abstinence from Cocaine Self-Administration is Associated with DNA Methylation Changes in Myelin Genes in the Corpus Callosum: a Preliminary Study

by Nielsen, David A., Huang, Wen, Hamon, Sara C., Maili, Lorena, Witkin, Brian M., Fox, Robert G., Cunningham, Kathryn A., Moeller, F. Gerard
Published 2012

Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized tri...

by Toth, Peter P., Hamon, Sara C., Jones, Steven R., Martin, Seth S., Joshi, Parag H., Kulkarni, Krishnaji R., Banerjee, Poulabi, Hanotin, Corinne, Roth, Eli M., McKenney, James M.
Published 2016

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

by Hopkins, Paul N., Defesche, Joep, Fouchier, Sigrid W., Bruckert, Eric, Luc, Gérald, Cariou, Bertrand, Sjouke, Barbara, Leren, Trond P., Harada-Shiba, Mariko, Mabuchi, Hiroshi, Rabès, Jean-Pierre, Carrié, Alain, van Heyningen, Charles, Carreau, Valérie, Farnier, Michel, Teoh, Yee P., Bourbon, Mafalda, Kawashiri, Masa-aki, Nohara, Atsushi, Soran, Handrean, Marais, A. David, Tada, Hayato, Abifadel, Marianne, Boileau, Catherine, Chanu, Bernard, Katsuda, Shoji, Kishimoto, Ichiro, Lambert, Gilles, Makino, Hisashi, Miyamoto, Yoshihiro, Pichelin, Matthieu, Yagi, Kunimasa, Yamagishi, Masakazu, Zair, Yassine, Mellis, Scott, Yancopoulos, George D., Stahl, Neil, Mendoza, Johanna, Du, Yunling, Hamon, Sara, Krempf, Michel, Swergold, Gary D.
Published 2015